Skip to main content
Erschienen in: Pediatric Cardiology 7/2012

01.10.2012 | Original Article

Relation Between Red Cell Distribution Width and Clinical Outcome After Surgery for Congenital Heart Disease in Children

verfasst von: Martial M. Massin

Erschienen in: Pediatric Cardiology | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Recent studies have reported a strong association between increased red cell distribution width (RDW) and the risk of adverse outcomes for adults with heart failure. This study investigated the association between preoperative RDW and postoperative clinical outcomes for children with cardiac disease. The relation between preoperative RDW and the length of postoperative stay was tested with 688 consecutive children undergoing surgery for congenital heart disease (CHD). The RDW was significantly higher in patients who died during the postoperative hospital stay (mean, 18.34 ± 4.69 vs 16.12 ± 2.84; p = 0.004). The risk of postoperative death was five times higher for patients with an RDW of 16% or more. In the general study population, RDW correlated with the intensive care unit (ICU) stay (p < 0.0001) and with the total hospital stay in the local population (p < 0.0001). The correlation between RDW and ICU stay was stronger for patients with acyanotic CHD (p < 0.0001) than for those with cyanotic CHD (p = 0.0007), and for the subpopulation of patients with acyanotic CHD and normal hemoglobin level (p < 0.0001) than for anemic patients with acyanotic CHD (p = 0.025). Preoperative RDW is a strong predictor of an adverse outcome in children undergoing surgery for CHD, especially in nonanemic patients, for whom it reflects an underlying inflammatory stress.
Literatur
1.
Zurück zum Zitat Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF Jr (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Cardiac Fail 16:230–238CrossRef Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF Jr (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Cardiac Fail 16:230–238CrossRef
2.
Zurück zum Zitat Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD (2010) Relation between red blood cell distribution width and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141:141–146PubMedCrossRef Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C, Marmur JD (2010) Relation between red blood cell distribution width and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141:141–146PubMedCrossRef
3.
Zurück zum Zitat Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105:312–317PubMedCrossRef Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105:312–317PubMedCrossRef
4.
Zurück zum Zitat Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103:2055–2059PubMedCrossRef Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103:2055–2059PubMedCrossRef
5.
Zurück zum Zitat Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeiffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, for the CHARM investigators (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40–47PubMedCrossRef Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeiffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, for the CHARM investigators (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40–47PubMedCrossRef
6.
Zurück zum Zitat Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158:659–666PubMedCrossRef Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158:659–666PubMedCrossRef
7.
Zurück zum Zitat Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, Geiger H, Scheuermann EH (2001) Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60:83–86PubMedCrossRef Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, Geiger H, Scheuermann EH (2001) Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 60:83–86PubMedCrossRef
8.
Zurück zum Zitat Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 104:868–872PubMedCrossRef Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 104:868–872PubMedCrossRef
9.
Zurück zum Zitat Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J Med 323:236–241CrossRef Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J Med 323:236–241CrossRef
10.
Zurück zum Zitat Mladenovic J, Adamson JW (1984) Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol 56:323–332PubMedCrossRef Mladenovic J, Adamson JW (1984) Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. Br J Haematol 56:323–332PubMedCrossRef
11.
Zurück zum Zitat Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77:723–727PubMedCrossRef Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77:723–727PubMedCrossRef
12.
Zurück zum Zitat Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20:83–90PubMedCrossRef Pierce CN, Larson DF (2005) Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20:83–90PubMedCrossRef
13.
Zurück zum Zitat Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M, for the Cholesterol and Recurrent Events (CARE) Trial Investigators (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117:163–168PubMedCrossRef Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M, for the Cholesterol and Recurrent Events (CARE) Trial Investigators (2008) Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 117:163–168PubMedCrossRef
14.
Zurück zum Zitat Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moyé LA, Otterstad JE, Pratt CM, Ponikowski P, Rouleau JL, Sestier F, Winkelmann BR, Young JB, Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators (2008) Results of a nonspecific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet 371:228–236PubMedCrossRef Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moyé LA, Otterstad JE, Pratt CM, Ponikowski P, Rouleau JL, Sestier F, Winkelmann BR, Young JB, Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators (2008) Results of a nonspecific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. Lancet 371:228–236PubMedCrossRef
15.
Zurück zum Zitat World Health Organization (2001) Iron deficiency anaemia: assessment, prevention, and control: a guide for programme managers. World Health Organization, Geneva (WHO/NHD/01.3) World Health Organization (2001) Iron deficiency anaemia: assessment, prevention, and control: a guide for programme managers. World Health Organization, Geneva (WHO/NHD/01.3)
Metadaten
Titel
Relation Between Red Cell Distribution Width and Clinical Outcome After Surgery for Congenital Heart Disease in Children
verfasst von
Martial M. Massin
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 7/2012
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0220-0

Weitere Artikel der Ausgabe 7/2012

Pediatric Cardiology 7/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.